Train Blast in Pakistan Kills at Least 20 Heightening Geopolitical Risk for Investors
Security Incident Near White House Raises Concerns Over Government Stability
Prediction Market Investments Surge Despite Regulatory Uncertainty
June Quarter Earnings Seen as Key Market Catalyst Amid Geopolitical Risks Says Expert
Zydus Lifesciences Revises Buyback Terms Price Hiked to Rs 1260 Share Count Reduced
Global Oil Supply Disruptions Reshape Energy Demand Patterns
FAF Q1 2026 Earnings EPS Beat by 256 Despite Mixed Market Reaction
Soligenix SNGX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Slips
CNSP Q1 2026 Earnings WiderThanExpected Loss but Stock Gains 7 on Strategic Updates
SPRB Q1 2026 Earnings Narrower Than Expected Loss Drives Positive Sentiment
WRB Q1 2026 Earnings Strong EPS Beat Driven by Solid Underwriting and Investment Results
Upbound Group Inc UPBD Rises 151 Testing Resistance Near 19 Amid Volume Patterns
Miluna Acquisition Corp MMTX Holds Steady at 1007 as SPAC Trading Remains Directionless
Forafric Global Warrants AFRIW Consolidate Near Resistance at 080
Sanofi ADS SNY Tests Support Levels After Modest Decline
Nasus Pharma NSRX Edges Higher Approaches Key Resistance Level
Universe Pharmaceuticals Inc UPC Surges 9 as Momentum Builds Near Key Resistance
Texas Ventures Acquisition III Warrants TVACW Climb 392 Approaching Key Resistance
OS Therapies OSTX Edges Higher Testing Key Levels After Modest Gain
Hercules Capital HTGC Rallies 209 as Stock Approaches Key Resistance Level
Zenta Group Limited ZGM Holds Steady at 165 as Trading Range Narrows
Sonoma Pharmaceuticals SNOA Edges Higher Testing Resistance at 113
Alberta to Hold Referendum on Separation from Canada Separatist Campaign Culminates
Allegion ALLE Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges
Veeva Systems VEEV Holds Above Support After Modest Gain Cautious Trend Continues
Navios Maritime Partners NMM Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds
ASND Q1 2026 Earnings EPS Misses Estimates as Ascendis Pharma Navigates Cost Pressures
JBLU Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Persist
CLS Q1 2026 Earnings EPS Surpasses Estimates Stock Rises
AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Sentiment
SIBONE Inc SIBN Q1 2026 Earnings Narrowerthanexpected Loss Drives 48 EPS Surprise
Immatics NV IMTX Q1 2026 Earnings EPS Misses Estimates as Clinical Progress Drives Share Gains